TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.
  1. Raoul Kamadjeu
  2. Announcements
  3. Friday, 18 January 2019
  4.  Subscribe via email

Innovations in Measles and Rubella Elimination in the African Region


Guest Editors:

  • Robert Davis: Measles Delegate, American Red Cross, Nairobi, Kenya
  • James L. Goodson: Senior Measles Scientist, Measles & Rubella Initiative Research and Innovation Workgroup Co-chair, U.S. Centers for Disease Control and Prevention, Atlanta, USA

Measles vaccination prevented more than 21 million deaths globally, during 2000–2017. Despite this enormous public health success, measles elimination efforts are facing various challenges including the inability of health systems to reach more children with the recommended two doses of measles-containing vaccine. Global first dose measles vaccination coverage has plateaued for nearly a decade, mass vaccination campaigns are not reaching all children, vaccine hesitancy fueled by increasingly vocal anti-vaccine groups is posing new challenges, rumours spread even faster than the disease through social media, sustained outbreaks are occurring in countries that had virtually eliminated measles.

The Pan African Medical Journal is calling for papers to be submitted for a special issue on Innovations in Measles and Rubella Elimination. The special issue aims to document innovations that have impacted or have the potential to help accelerate progress toward measles elimination targets by focusing on immunization service delivery, community demand for vaccination and advocacy, injection safety, supply chain management and cold chain, immunization financing, measles laboratory-supported surveillance, campaign planning an implementation, outbreak response, and more.

Submissions will be accepted in the following categories:

  • Research
  • Short communications
  • Case studies
  • Expert opinion
  • Commentaries

All manuscripts need to adhere to the Pan African Medical Journal instructions for authors [http://www.panafrican-med-journal.com/instruction.php] and be submitted through the online journal manuscript submission system (Submit as Supplement – Innovation in Measles and Rubella Elimination).

Expected date of publication: Fourth quarter of 2019

For questions and comments, contact the supplement guest editors or the editorial office at: editor@panafrican-med-journal.com

The editorial office - Pan African Medical Journal

 

The Pan African Medical Journal (ISSN: 1937-8688). Kenya: 3rd Floor, Park Suite Building, Parkland Road, Nairobi. PoBox 38583-00100, tel: +254 (0)20-520-4356 | Cameroon: Immeuble TechnoPark Essos, Yaounde, PoBox: 10020 Yaounde, tel: +237 (0)24-309-5880.

References
  1. https://www.panafrican-med-journal.com/mailalert/MA14122018.htm


There are no replies made for this post yet.
However, you are not allowed to reply to this post.